Saturday, May 31, 2014

Vivek Oberoi Starts 'No Tobacco Day' Campaign

Along with BEST, Vivek Oberoi started the 'No Tobacco day' campaign to commemorate 'World No Tobacco Day' in Mumbai. Speaking at the event, the 37-year old actor said that it was his dream to make India Tobacco free AND SAID, "I am very happy to see that BEST has taken such a good initiative. I have been associated as a brand ambassador with 'World No Tobacco Day' from past 12-13 years. This is not just a day but also a dream to make India Tobacco free". World ...

Read More
editor health

New Study Uncovers Clues to the Genetic Cause of Schizophrenia

Number and nature of mutations influence an individual's risk of developing schizophrenia, finds new study published in Neuron. The findings could have important implications for the early detection and treatment of schizophrenia. Maria Karayiorgou, MD, professor of psychiatry and Joseph Gogos, MD, PhD, professor of physiology and cellular biophysics and of neuroscience, and their team sequenced the "exome"-the region of the human genome that codes for proteins-of ...

Read More
editor health

Dengue Outbreak Hits Campinas Ahead of World Cup

With World Cup less than two weeks away, Brazilian city of Campinas, where Portugal and Nigeria will be training, is struggling to deal with a growing dengue fever epidemic. Workers in Campinas have embarked on a huge operation to eradicate mosquitos, which spread the disease, before the Portuguese and Nigerian teams arrive. Some 32,384 people have been infected by dengue this year in the southeastern city about one hour from Sao Paulo. At least three ...

Read More
editor health

Results Show Experimental Drug to be Effective in Some Patients With Pancreatic or Ovarian Cancer

Results of the phase I clinical trial of the investigational agent DMOT4039A has found the drug to be well tolerated in some patients and display initial evidence of anti-cancer activity among patients suffering from pancreatic and ovarian cancers, researchers told the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO). The drug is in fact a combination of a chemotherapeutic agent with an antibody, technically called an antibody-drug conjugate ...

Read More
editor health

Use of Rectal Artesunate for Severe Malaria Explored in Cochrane Review

An independent review of the effects of pre-referral rectal artesunate for people with severe malaria was conducted by researchers from the Cochrane Infectious Diseases Group, hosted at LSTM. The review is published in the Cochrane Library. The review follows a large trial of rectal artesunate in 2009 which led the World Health Organization to recommend its use.Severe malaria is a serious medical condition caused by infection with the iPlasmodium/i parasite. ...

Read More
editor health